Survivin inhibits anti-growth effect of p53 activated by aurora B

作者: Ji-Eun Jung , Tae-Kyung Kim , Joong-Seob Lee , Se-Yeong Oh , Sungwook Kwak

DOI: 10.1016/J.BBRC.2005.08.235

关键词:

摘要: Genomic instability and apoptosis evasion are hallmarks of cancer, but the molecular mechanisms governing these processes remain elusive. Here, we found that survivin, a member apoptosis-inhibiting gene family, aurora B kinase, chromosomal passenger protein, were co-overexpressed in various glioblastoma cell lines tumors. Notably, exogenous introduction human BJ cells was shown to decrease growth increase senescence-associated beta-galactosidase activity by activation p53 tumor suppressor. However, overexpression failed inhibit proliferation U87MG transduced with dominant-negative as well p53(-/-) mouse astrocytes. Aurora centrosome amplification Survivin induce anchorage-independent anti-proliferation drug-sensitive caused B. Overexpression both survivin further accelerated cells. Taken together, present study indicates should accelerate tumorigenesis inhibiting anti-proliferative effect suppressor is activated normal containing intact p53.

参考文章(32)
Masaaki Tatsuka, Shiho Suto, Mikio Tanino, Fumio Suzuki, Takahide Ota, Masayo Maeda, Yasuhiko Terada, Zhen Bo Han, Hiroshi Katayama, Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Research. ,vol. 62, pp. 5168- 5177 ,(2002)
Fengzhi Li, Grazia Ambrosini, Emily Y. Chu, Janet Plescia, Simona Tognin, Pier Carlo Marchisio, Dario C. Altieri, Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. ,vol. 396, pp. 580- 584 ,(1998) , 10.1038/25141
Hidemasa Goto, Yoshihiro Yasui, Erich A. Nigg, Masaki Inagaki, Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes to Cells. ,vol. 7, pp. 11- 17 ,(2002) , 10.1046/J.1356-9597.2001.00498.X
Arnab Chakravarti, Elizabeth Noll, Peter McL Black, Daniel F Finkelstein, Dianne M Finkelstein, Nicholas J Dyson, Jay S Loeffler, Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas Journal of Clinical Oncology. ,vol. 20, pp. 1063- 1068 ,(2002) , 10.1200/JCO.20.4.1063
John C. Reed, The Survivin saga goes in vivo Journal of Clinical Investigation. ,vol. 108, pp. 965- 969 ,(2001) , 10.1172/JCI14123
Richard R. Adams, Mar Carmena, William C. Earnshaw, Chromosomal passengers and the (aurora) ABCs of mitosis. Trends in Cell Biology. ,vol. 11, pp. 49- 54 ,(2001) , 10.1016/S0962-8924(00)01880-8
Marie Classon, Ed Harlow, The retinoblastoma tumour suppressor in development and cancer Nature Reviews Cancer. ,vol. 2, pp. 910- 917 ,(2002) , 10.1038/NRC950
Wafik S El-Deiry, Takashi Tokino, Victor E Velculescu, Daniel B Levy, Ramon Parsons, Jeffrey M Trent, David Lin, W Edward Mercer, Kenneth W Kinzler, Bert Vogelstein, WAF1, a potential mediator of p53 tumor suppression Cell. ,vol. 75, pp. 817- 825 ,(1993) , 10.1016/0092-8674(93)90500-P
Hans-Stefan Hofmann, Andreas Simm, Andreas Hammer, Rolf-Edgar Silber, Babett Bartling, Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer Journal of Cancer Research and Clinical Oncology. ,vol. 128, pp. 554- 560 ,(2002) , 10.1007/S00432-002-0364-Z
Patrick Chène, Inhibiting the p53–MDM2 interaction: an important target for cancer therapy Nature Reviews Cancer. ,vol. 3, pp. 102- 109 ,(2003) , 10.1038/NRC991